Hui‐Ling Zhen

4.5k citations
99 papers · 2.8k · 2 hit papers · h-index 26

Impact in

Papers in

Hui‐Ling Zhen

93 papers receiving 2.8k citations

Hui‐Ling Zhen's Hit Papers

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study 2020 · 975 citations
9750+2+4Years since publication250500750

Peers

Hui‐Ling Zhen
Comparison fields: 5 of 133
  • Statistical and Nonlinear Physics 698
  • Oncology 854
  • Modeling and Simulation 136
  • Surgery 1.2k
  • Cancer Research 249
Replace Steffen Löck with:
Steffen Löck Germany
Di Dong China
Federica Cattani Italy
Thomas E. Yankeelov United States
Zhongqing Wang China
W. Heidenreich Germany
Claudio Giberti Italy
A. Nisbet United Kingdom
Lech Papież United States
Lei Li China
Hui‐Ling Zhen relative to Steffen Löck Germany Steffen Löck's profile →
Citations per field
00.5×10.5×
Steffen Löck · 1×
Citations per year

Countries citing papers authored by Hui‐Ling Zhen

Since Specialization
Citations

This map shows the geographic impact of Hui‐Ling Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Ling Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Ling Zhen more than expected).

Fields of papers citing papers by Hui‐Ling Zhen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Ling Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Ling Zhen. The network helps show where Hui‐Ling Zhen may publish in the future.

Co-authors

The 25 scholars most cited alongside Hui‐Ling Zhen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hui‐Ling Zhen Line = papers co-authored together Hui‐Ling Zhen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Hit paper breakdown →
2020975
2
Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib
Hit paper breakdown →
2020191
3 2020125
4 201666
5 201558
6 201553
7 201552
8 202148
9 201448
10 201448
11 202246
12 201644
13 201443
14 201942
15 201841
16 201439
17 201538
18 201837
19 201636
20 201836

About Hui‐Ling Zhen

Hui‐Ling Zhen is a scholar working on Statistical and Nonlinear Physics, Atomic and Molecular Physics, and Optics, Molecular Biology, Surgery and Oncology, having authored 99 papers that have together received 2.8k indexed citations. Recurring topics across this work include Nonlinear Waves and Solitons (39 papers), Nonlinear Photonic Systems (36 papers), Fibroblast Growth Factor Research (18 papers), Advanced Fiber Laser Technologies (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Advanced Mathematical Physics Problems (8 papers) and Eosinophilic Disorders and Syndromes (7 papers). The work is most often cited by research in Statistical and Nonlinear Physics (698 citations), Oncology (854 citations), Modeling and Simulation (136 citations), Surgery (1.2k citations) and Cancer Research (249 citations). Hui‐Ling Zhen has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Bo Tian, Wen‐Rong Sun, Luis Féliz, Davide Melisi, Antoine Hollebecque, Christine Lihou, Mitesh J. Borad, Arndt Vogel, Ghassan K. Abou‐Alfa and Eric Van Cutsem. Their work appears in journals such as Physics of Plasmas, Journal of Clinical Oncology, Annals of Oncology, Journal of Modern Optics and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact